Clinical trials
Multicenter Study clinical trials
Below are recruiting multicenter study clinical trials, each written for real people, not researchers. We’re tracking 405 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05864638Recruiting
Registry study of clot-removal treatment for acute stroke
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
ShanghaiAges Any age - NCT07454603Recruiting
Blood test for prostate cancer risk
This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.
Branford, ConnecticutAges 45–80 - NCT07458074Recruiting
Italian Study on Radial VAD Support
This study looks at how well continuous-flow heart pumps (VADs) work in people with advanced heart failure. It aims to improve care and outcomes for adults receiving these devices.
Bergamo, BergamoAges 18 years+ - NCT07438691Recruiting
Comparing surgical methods for children with anorectal malformations
This study compares different surgical techniques for children with a specific type of anorectal malformation (perineal or vestibular fistula). It aims to see which surgery leads to better outcomes.
Florence, FlorenceAges birth–18 years - NCT07417813Recruiting
Lemborexant for insomnia in people with mental health conditions
This study tests if lemborexant, a sleep medication, can help people with both a mental health condition and insomnia. You would take the medicine as prescribed and complete questionnaires over 2 months.
Suzhou, JiangsuAges 18 years+ - NCT07424664RecruitingPhase 2
Combination targeted drug and immunotherapy for recurrent gynecologic cancers
This trial tests a combination of two new drugs—becotatug vedotin (targeted therapy) and zimberelimab (immunotherapy)—in people with recurrent or metastatic cervical, vulvar, or vaginal cancer. The goal is to see if this combination works after standard treatments like platinum chemotherapy and immunotherapy have been tried.
Wuhan, HubeiAges 18–75 - NCT07418294Recruiting
Fluctuation imaging for liver hemangioma diagnosis
This study tests a new ultrasound technique called fluctuation imaging to see if it can accurately diagnose hepatic hemangiomas (a common type of non-cancerous liver tumor). If you have a liver spot detected on an ultrasound, this study may help confirm what it is without needing a biopsy.
Seoul, Seodaemun-guAges 19 years+ - NCT06564493RecruitingPhase 2
Radiation conditioning before sibling stem cell transplant for pediatric ALL
This study tests two types of radiation-based conditioning (TBI or TMLI) before a stem cell transplant from a matched sibling donor, in children with ALL that is in remission. The goal is to see which approach works better and is safer.
Zhengzhou, HenanAges 1–17 - NCT06557161RecruitingPhase 2
Stem cell transplant with TBI or TMLI for adult ALL
This trial tests two different conditioning regimens (total body irradiation or total marrow/lymphoid irradiation) before a stem cell transplant from a matched sibling donor for adults with acute lymphoblastic leukemia (ALL) that is in remission. The goal is to see which regimen works better and has fewer side effects.
Zhengzhou, HenanAges 18–65 - NCT06559345RecruitingPhase 2
Stem cell transplant study for children with ALL in remission
This trial tests a stem cell transplant using a half-matched family donor for children with acute lymphoblastic leukemia (ALL) that is in remission. It compares two different types of radiation conditioning to prepare the body for the new cells, with the goal of improving outcomes.
Zhengzhou, HenanAges 1–17 - NCT06564545RecruitingPhase 2
Radiation-based transplant preparation for adult ALL
This trial studies a new way to prepare adults with ALL for a stem cell transplant from a half-matched family donor. It compares two types of radiation-based conditioning to see which works better and has fewer side effects.
Zhengzhou, HenanAges 18–65 - NCT07378358Recruiting
AI for urology diagnosis and treatment
This study is testing how well AI can help with diagnosis and treatment by looking at medical records of patients from four hospitals, specifically those with urological conditions. It's a way to see if AI can improve care without needing any new tests or visits.
FuzhouAges 18 years+ - NCT06849193Recruiting
Predicting treatment outcomes in advanced bile duct cancer
This study looks at how well current chemotherapy and immunotherapy work for advanced bile duct or gallbladder cancers that cannot be removed by surgery. Researchers will collect data from multiple centers to build a model that helps predict how patients may respond to treatment.
Nanjing, JiangsuAges 18 years+ - NCT07351669Recruiting
Spectral CT to check TACE response in liver cancer
This study uses a special type of CT scan (spectral CT) to see how well liver cancer has responded to a previous TACE treatment. If you've already had TACE for your liver cancer, this scan may help your doctors decide on the next steps, such as surgery or another procedure.
NanjingAges 18–75 - NCT07312318Recruiting
AI predicts heart artery changes after stenting
This study uses artificial intelligence to predict how heart arteries might change after a stent procedure (PCI). Researchers will collect blood samples and medical data to develop a tool that could help doctors make better treatment decisions.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07300449RecruitingPhase 2
Predicting chemo response in children with hepatoblastoma
This trial tests a new way to see if chemotherapy will work for children with hepatoblastoma, a type of liver cancer. It uses a blood test (ctDNA 5hmc) to help predict treatment success and monitor if the cancer comes back.
Guangzhou, GuangdongAges Up to 18 years - NCT07289711Recruiting
Study of ARDS subtypes for targeted treatment
This study looks at different types of inflammation in patients with Acute Respiratory Distress Syndrome (ARDS), a serious lung condition. It aims to find which treatments work best for each subtype.
Nanjing, JiangsuAges 18 years+ - NCT07289763RecruitingPhase 2
Study of SHR-2173 for primary membranous nephropathy
This trial tests an investigational drug called SHR-2173 for people with primary membranous nephropathy, a kidney disease that causes protein leakage. The study aims to see if the drug is safe and effective, and it involves periodic injections and monitoring.
Nanjing, JiangsuAges 18–75 - NCT06891326Recruiting
Testing tACS for depression relief
This study tests if a non-invasive brain stimulation technique called transcranial alternating current stimulation (tACS) can safely treat depression. It uses mild electrical pulses on the scalp to help improve mood.
ShanghaiAges 18–65 - NCT07253129Recruiting
Stem cell transplant study for T-cell lymphoma patients with partial response
This study compares two types of stem cell transplants (from a donor or your own cells) for people with certain T-cell lymphomas who had only a partial response to first chemotherapy. It aims to see which approach may work better.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT07255378Recruiting
Vasopressin for septic shock in the ICU
This study observes how the medication vasopressin works when added to standard treatment for septic shock in the ICU. It helps doctors understand if vasopressin improves outcomes for patients with severe infection and low blood pressure.
Terrassa, BARCELONAAges 18 years+ - NCT07233811Recruiting
Same-day discharge after robotic hysterectomy
This trial tests if it's safe and beneficial to go home the same day after robotic hysterectomy, compared to staying overnight. It includes women with both benign conditions and endometrial cancer, regardless of weight or uterus size.
StockholmAges 18–75 - NCT06908980Recruiting
Predicting survival after gallbladder removal for infected gallbladder
This study is testing a tool to predict survival after gallbladder removal for people with acute cholecystitis caused by gallstones. By joining, you help doctors better assess risk and improve care for future patients.
Pavia, PaviaAges 18 years+ - NCT07215390RecruitingPhase 2
Study of APL-3007 plus Syfovre for geographic atrophy
This trial tests whether a new drug called APL-3007, when added to your current Syfovre treatment, can slow the progression of geographic atrophy (an advanced form of dry age-related macular degeneration). It's for people who have already been on Syfovre for at least 6 months.
Gilbert, ArizonaAges 60 years+
Hear when a new Multicenter Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for multicenter study?
- Yes. Clin2 currently lists 405 recruiting multicenter study studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a multicenter study trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a multicenter study trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.